#astrazeneca

#astrazeneca

Whether you get it from a vaccine or an infection, COVID-19 immunity does not last forever.In a study published May 3 in JAMA Network Open, researchers combed through studies to determine just how long protection from the shots endures.The scientists, led by a team from Italy, analyzed 40 studies that documented people's vaccination status and their subsequent infections with COVID-19, confirmed by lab tests.

Young women who received at least one dose of the Covid vaccine made by AstraZeneca may have been more likely to die of a heart problem in the 12 weeks after their vaccination, according to an analysis of immunization and death records in Britain released on Monday.Those findings carry a big caveat: Britain withdrew AstraZeneca's vaccine use for young people under 30 in April 2021, citing the risk of rare but dangerous blood clots.

After hours of deliberation over safety concerns, a Food and Drug Administration advisory panel on Wednesday recommended approval of a second vaccine for the respiratory syncytial virus in older adults, advancing the first shots against an illness that can be deadly for the very young and the very old.

The boss of Britain's biggest drugmaker has said that the UK and the rest of Europe are falling behind China and the US in the creation of biotech firms and clinical trials of new medicines.Pascal Soriot, chief executive of AstraZeneca, said that while China had seen an explosion of biotech companies and a rapid expansion of clinical trials, the UK and EU had posted declines.

Rishi Sunak's government will not lay out its response to rival US and EU green industrial strategies until the autumn, chancellor Jeremy Hunt has said.Business leaders are expecting a host of climate and energy policies on Thursday that would spur Britain's investment in green technology.But Mr Hunt said the government would not offer a full national response to major green investment initiatives made in the US and EU until the autumn.

Recent news about the UK economy has been a series of staggering highs and lows.The highs have often featured UK companies.Profits have reached record levels, as in turn have the indices that track the value of those companies' shares, providing a bonanza for executives and shareholders alike.The lows have featured British households.

The Food and Drug Administration on Wednesday approved GSK's vaccine for the respiratory syncytial virus, or R.S.V., for adults who are 60 and older, the company said.The vaccine, to be sold as Arexvy, appears to be the first in the world approved for sale to protect older adults.Image An transmission electron microscopic image of R.S.V.Credit...Centers for Disease Control and Prevention The F.D.A. estimates that R.S.V. is associated with 6,000 to 10,000 deaths each year in adults 65 and older and at least 60,000 hospitalizations in that age group.

Jeremy Hunt has launched a flurry of tax breaks to encourage investment by businesses after the double blow of microchip designer Arm opting for a New York stock market listing and AstraZeneca deciding to build a new factory in Dublin.Businesses that invest in IT equipment and machinery will be able to claim back the cost by writing it off against tax on their profits, the chancellor announced in his budget on Wednesday.

A new drug to prevent severe RSV infections could soon be available for young babies.Up to 80,000 young kids get hospitalized with RSV each year in the U.S. ARI SHAPIRO, HOST: Up to 80,000 young kids get hospitalized with RSV each year in the U.S, and it was especially bad this past season.But there's a new drug that could bring those numbers down significantly.

For free real time breaking news alerts sent straight to your inbox sign up to our breaking news emails Sign up to our free breaking news emails The papers at the end of the working week are led by soaring energy bills and interest rates, as well as the earthquakes in the Middle East and the search for missing mother Nicola Bulley.

WASHINGTON The overdose-reversing drug naloxone should be made available over the counter to aid the national response to the opioid crisis, U.S. health advisers said Wednesday.The panel of Food and Drug Administration experts voted unanimously in favor of the switch after a full day of presentations and discussions centered on whether untrained users would be able to safely and effectively use the nasal spray in emergency situations.

The US Food and Drug Administration on Thursday halted the emergency use authorization of Evusheld because it does not appear to protect against Covid-19 from viral variants currently circulating in the United States.Evusheld is a monoclonal antibody therapy used to prevent Covid-19 in immunocompromised people, who are less likely to generate an immune response from Covid-19 vaccination.

The 87-acre field of weeds and rubble with a view of Treasure Island, downtown San Francisco, the Berkeley shoreline and the Bay Bridge was once Stauffer Chemical.Climate models show this acreage nearly surrounded by water in just a few decades.The company dumped iron pyrite cylinders into the marsh near the site and made pesticides, herbicides and fertilizers.

Concerns around the AstraZeneca Covid vaccine were overblown by the media, the company's chief executive has said.Sir Pascal Soriot was speaking after he was knighted by the King at Windsor Castle on Wednesday.Among those also honoured at the investiture ceremony was presenter Matt Baker, actor Damian Lewis, Coronation Street star William Roache, and film director Sir John Boorman.

Whenever Andrew Bailey, the governor of the Bank of England, talks about the economy, he is forced to mention the toll taken by Brexit.Business leaders, initially reluctant to criticise the Tory decision to quit the EU, have begun to find their voice.Most recently, leading City figure Guy Hands called Brexit a complete disaster and a bunch of total lies that has harmed large parts of the economy.

For free real time breaking news alerts sent straight to your inbox sign up to our breaking news emails Sign up to our free breaking news emails Rishi Sunak is facing rebellion from a coalition of Conservative MPs over April's planned rise in corporation tax.The leaders of several backbench Tory factions have written to the prime minister to urge him to abandon his plan to hike the tax from 19 to 25 per cent ahead of the March Budget.

Before we get on to Brexit don't worry: we shall I want to draw attention to what I regard as the epitome of the meanness and duplicity of what is indubitably the worst government of most of our lifetimes.Sorry, did I say government?A neighbour asked me the other day if I was aware of a new oxymoron.

The US Food and Drug Administration has accepted a biologics license application for a long-acting antibody for the prevention of lower respiratory tract infections caused by the respiratory syncytial virus, according to the developers of the antibody.If approved, it could be available for use in some infants and toddlers later this year.